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Abstract: Introduction: Mental disorders are the most prevalent health problems in the world. 23.6% of Iranians have at
least one psychological disorder. Men usually neglect their mental health issues, and their top priority mental
health disorders should be determined for health planning. Methods: International databases including Med-
Line, Scopus, Web of Science, ProQuest, and SID national database were searched from 2015 to October 2020.
The latest reported prevalence and percent of total DALY (Disability-adjusted life year), their difference between
sexes as well as the expert panel’s opinion about mental disorders were gathered in a matrix based on the Three-
Dimensional Combined Approach Matrix (3D-CAM). Each item got a rank and prioritization was made base on
mean rank. Results: Eight studies were included. The most prevalent mental disorders among the Iranian male
population were Major Anxiety Disorders (MADs, 12%) and the highest burden belonged to Major depressive
disorder (MDD) comprising 2.88% of the total DALY. Considering all parameters, the highest priority was the
Drug Use Disorders (DUD) followed by Alcohol Use disorders (AUDs), Conduct disorder, MADs, Bipolar disor-
der, MDD, and Schizophrenia, respectively. Conclusion: Men are extremely affected by drug and alcohol use
disorders in Iran and also there is a lack of practical screening and effective interventional programs for these
disorders in the primary health care system. More intensive harm reduction programs are needed for decreasing
devastating consequences of any substance use disorders as well as improving mental health literacy and raising
awareness toward risk perception for preventive and controlling purposes.
Keywords: Mental disorders; Disease burden; Health priorities
Cite this article as: Hajebi A, Aliakbari F, Shojaeefar E, Hosseini M A. Prioritization of Iranian Male Mental Disorders Based on latest Preva-
lence, Burden, Male/Female Ratio and Expert Pane; a Systematic Review. Mens Health J. 2021; 5(1): e24.
1. Introduction
Mental disorders are the most prevalent health problems in
the world and often have an early onset in life, they are con-
tributing significantly to the global disease burden as well
(1). Currently, there is an alarming increase in the inci-
dence of mental disorders around the world, which causes
considerable morbidity (2). Studies have shown that the
prevalence of mental disorders varies between 9.6 and 27.8%
in the general population (3) The Iran mental health sur-
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vey has shown that the one-year prevalence of any psychi-
atric disorder was 23.6% (4). Mental disorders include var-
ious modes such as depression, generalized anxiety disor-
ders, post-traumatic stress disorder, social anxiety disorder
and panic disorders which are the most important common
mental health disorders affecting a large proportion (25%)
of the world’s population in both developing and developed
countries (5). Mental health problems are related to poor ed-
ucational achievement, unemployment, interpersonal diffi-
culties and maladaptive parenting behaviors. Mental disor-
ders may interpose with developmental duties in different
periods (6).
Comorbidity in mental disorders is widespread (maximum:
50%) and individuals who have one mental disorder also
have at least another comorbid mental disorder (7). Comor-
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bidity can be an index of more severity and chronicity of
mental disorders and it is needed to be considered system-
atically in any clinical setting. Prevention of secondary con-
ditions (comorbidities) is based on the effective management
of primary conditions (8). Men are less concerned about their
health problems especially those related to mental health
since they are worried about their social role being destroyed
since a high stigma is associated with these types of disorders
(9, 10). Because of the low facilities and budget available for
covering all mental health problems, we should focus on the
most important and cost-effective targets either in research
or the treatment sectors. Therefore, we aimed to find the top
priorities of mental health disorders in men to be addressed
in future health planning goals that may be made by policy-
makers or researchers.
2. Methods
This study aimed to collect all latest reports about the preva-
lence and burden of mental health disorders in the general
population in Iran. Accordingly, this PICO was considered
to include all systematic reviews and nationwide studies in
this area from the last 5 years. Considering the following
keywords: “prevalence”, “burden”, “mental disorders”, “psy-
chiatric disorders”, and “Iran”, an electronic search was done
in international databases including Scopus, Medline, Web
of Science, ProQuest, Google Scholar, and SID as a national
database from 2015 until October 2020, eligible studies could
have been published in either English or Farsi. The process
of selecting articles was completed by two independent re-
searchers in the field of mental health and general medicine.
Exclusion criteria were non-Iranian participants and studies
about interventions and correlations etc. or studies about
specific groups (non-general population) and studies that
were not systematic reviews or national surveys. Since there
was only one source of burden of mental disorders, we con-
sidered only those disorders listed in that source. Accord-
ingly, those studies that had reported the latest prevalence
of selected disorders, were included. Extracted data were en-
tered into a table which included bibliographic information
of studies (author’s name, publication year), study type, and
main study achievements about the prevalence of mental
disorders. According to Three-Dimensional Combined Ap-
proach Matrix (3D-CAM) (11), the prioritization was made
based on the mean rank of prevalence in men; male/female
ratio of prevalence; DALY in men; male/female ratio of DALY
and the ranking which was done by the expert panel who
were asked about the least to most covered research topics in
this area. Test of heterogeneity, subgroup analysis, risk of bias
and meta-analysis were not applicable because we used the
latest data for each disorder that themselves resulted from ei-
ther a meta-analysis or a national survey and there weren’t
numerus records for each of given disorder to be pooled to-
gether.
3. Results
As shown in figure 1, at the initial phase of the electronic
search, 211 articles were retrieved. After removing dupli-
cates, 85 studies were screened for eligibility. Finally, eight
studies were summarized. The agreement between search
results were almost perfect between two researchers (kappa
= 91.5). The most prevalent mental disorders among the Ira-
nian male population were Major Anxiety Disorders (MADs,
12%, CI95%: 10.6-13.4) (Table1) and the highest burden
belonged to Major Depressive Disorder (MDD) with 2.88%
(CI95%: 2.05-3.87) of total DALYs. The highest male/female
ratio was the prevalence of Alcohol Use Disorders (AUDs)
which indicated that the prevalence of AUDs in men is 22.8
folds higher than in women. Considering all parameters in-
cluding prevalence, burden, male/female ratio and the least
to most covered research topics according to expert panel the
highest priority was the Drug Use Disorders (DUD) followed
by Alcohol Use disorders (AUDs), Conduct disorder, MADs,
Bipolar, MDD, and Schizophrenia respectively (Table2).
4. Discussion
Our matrix of prioritization revealed that the top priority of
mental health disorders in Iranian men belonged to DUDs
and AUDs which mainly resulted by the huge difference be-
tween their prevalence in men and women. Indeed, men in
Iran are suffering from these disorders almost 10-23 times
more than women. This gender gap is also reported in other
countries but some studies mentioned that the sex difference
is narrowing because of socio-structural changes that have
been occurring in developing countries. Besides the inten-
sive programs which are needed for harm reduction in both
sexes, despite the functional consequence of DUDs tends to
be more severe in women, and male drug users are extremely
higher than female ones and this needs more attention (20).
Based on the expert panel’s opinion, AUDs are one of the
least-covered research topics in Iran but from the aspect of
global concern, AUDs are considered as the most prevalent
mental disorders mostly in high-income and upper-middle-
income countries; and are also associated with high mortal-
ity and burden of disease, mainly because of the adverse out-
comes like liver cirrhosis or injuries (21). Since high stigma is
associated with these disorders, AUDs are usually neglected,
and also there are no practical screening programs for them
in primary health care, it is suggested to implement a clini-
cal intervention for these disorders in a supportive commu-
nity environment (9). Despite the presence of most required
rules and guidelines of standard alcohol policy including im-
plementation of AUDs screening in PHC in Iran, since the al-
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cohol use in Iran is totally banned, we are facing an under-
estimate in current use and also even unmet urgent medical
cares for methanol poisoning cases (22).
Conduct disorder which is our major concern in adolescents
younger than 18 years has a considerable sex difference in
Iran and also this disorder got the first rank in terms of least-
covered research topic from expert panel, these caused it
to get the third priority in our study. Although in compar-
ison with global statistics (3.6% and 1.5% in male and fe-
male respectively) (23) the overall prevalence of this disor-
der is significantly lower in our country, but we have a worse
condition in male/female ratio (4.57 versus 2.4) (23), so we
should take more powerful steps to care for our children es-
pecially boys, against such predisposing conditions such as
low school achievement, disrupted families, poor parental
supervision, low childhood socioeconomic status, and low
family income (24, 25) and also it is suggested to the Iranian
researchers to pay more attention to this neglected research
area.
Although the MADs which mainly include Generalized Anx-
iety Disorder (GAD), Obsessive-Compulsive Disorder (OCD),
Panic Disorder, Post-Traumatic Stress Disorder (PTSD) and
Social Phobia (or Social Anxiety Disorder) are less prevalent
in men than women, they got the forth priority because of
their higher overall prevalence among all mental disorders
(12% and 19.4% in men and women respectively), indeed
these types of mental disorders are the most prevalent men-
tal disorders in both sex around the world (13, 23). Also,
there are many studies on these topics. However, consid-
ering the burden of disease, they have the same burden as
DUDs. There are several major risk factors including unem-
ployment, low socioeconomic status, and urban residency
for these type of mental disorders and a recent study by Ha-
jebi and colleagues found that MADs are more prevalent in
middle-aged men and also MADs cause more days out of role
in men than women (13).
Compared with global prevalence (1.5%), Bipolar disorder
has a relatively better condition in Iran (4). One of the most
important concerns about this disorder is that the rate of sui-
cide in these patients is 20-30 times higher than the general
population (26). The most-covered research topic among our
list was MDD. Iranian men were suffering from depression
about half of the amount seen in women and also MDD has
a relatively low overall prevalence in men so located in our
lower level of priority, but unfortunately, this disorder has the
highest burden of disease among all mental health disorders
in Iran and should not be neglected in men because they are
less likely to seek professional help in this regard than women
(10). With respect to schizophrenia, we have partially the
same condition as global prevalence (27).
The limitation of our study was that the latest data about the
prevalence of one of our disorders (MDD) was extracted from
a systematic review article that was different from other dis-
orders that were extracted from national surveys.
5. Conclusion
Since men usually neglect their health problems especially
mental health issues they are extremely affected by DUD
and AUDs in Iran when compared with women and also
as a result of some legal issues the screening and interven-
tional programs for these disorders are not practical and
effective in PHC. More intensive harm reduction programs
are needed for decreasing devastating consequences of any
DUDs as well as preventive and controlling programs which
would be achieved by improving mental health literacy and
raising awareness toward risk perception. More studies on
men’s mental health specially in fields of conduct disorder
and AUDs are suggested to be conducted that may have been
neglected by men, researchers, and health policymakers.
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Figure 1: PRISMA flow diagram of electronic search and selection process of included studies.
Table 1: Prevalence of mental disorders in the national survey or systematic review studies in Iran.
First author, year [ref.] Study type Total sample
size
Prevalence of disorder in male
(95% CI)
Prevalence of disorder in female
(95% CI)
Gharraee. B., 2019 (12) Systematic review 37867 MDD: 2.3% (1.6-3.6) MDD: 4.8% (3.6-5.6)
Hajebi A., 2018 (13) National survey 7886 MADs 12% (10.6-13.4) MADs: 19.4% (17.9-20.9)
Amin-Esmaeili M, 2017 (14) National survey 7840 AUDs: 1.83 (1.22-2.43) AUDs: 0.08 (0-0.16)
Amin-Esmaeili M, 2016 (15) National survey 7841 DUDs: 3.79% DUDs:0.35%




Sharifi V., 2015 (4) National survey 7886 Bipolar: 1.1% (0.7-1.6) Bipolar: 0.8%(0.5-1.1)
Charlson FJ., 2018 (17) Global NA Schizophrenia: 0.19% (0.17-0.22)
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Table 2: Prioritization of mental disorders based on table 1; the study of the Burden of Mental Disorders in the Eastern Mediterranean Region
(18) and Institute of Health metrics and evaluation )IHME( in Iran (19) and ranking which was done by expert panel who were asked about the















3.79 (2) (3.79/0.35) =10.8 (2) 2.43 (3) (2.43/0.91)=2.67 (1) 5 2.6
Alcohol use
disorders
1.83 (4) (1.83/0.08)=22.8 (1) 0.27 (7) (0.27/0.12)=2.25 (2) 2 3.2
Conduct
disorder
1.28 (5) (1.28/0.28) = 4.57 (3) 0.32 (6) (0.32/0.18)= 1.77 (3) 1 3.6
Major anxiety
disorders
12 (1) (12/19.4)= 0.62 (6) 2.44 (2) (2.44/3.99)= 0.61 (7) 6 4.4
Bipolar 1.1 (6) (1.1/0.8)= 1.37 (4) 0.71 (5) (0.71/0.91)= 0.78 (5) 3 4.6
Major depressive
disorder
2.3 (3) (2.3/4.8)= 0.48 (7) 2.88 (1) (2.88/5.46)= 0.64 (6) 7 4.8
Schizophrenia 0.19 (7) (0.19/0.19)= 1 (5) 0.8 (4) (0.8/0.8)= 1 (4) 4 4.8
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